Literature DB >> 31687098

Red Yeast Rice for Hypercholesterolemia.

Arrigo F G Cicero1,2, Federica Fogacci1, Maciej Banach3,4,5.   

Abstract

The extract of red yeast rice (RYR) is the most effective cholesterol-lowering nutraceutical on the market. In particular, its effectiveness is directly related to the amount of monacolin K within the extract (up to 10 mg/day). Consuming monacolin K on a daily basis reduces low-density lipoprotein (LDL) cholesterol plasma levels between 15% and 25% within 6 to 8 weeks. Certainly, the decrease in LDL-cholesterol is accompanied by a similar reduction in total cholesterol, non-high-density lipoprotein cholesterol, plasma apolipoprotein B, matrix metalloproteinases 2 and 9, and high-sensitivity C-reactive protein. Furthermore, the RYR lipid-lowering effect is associated with significant improvements in pulse wave velocity and endothelial function, which are validated and reliable biomarker tools able to detect vascular aging. Although it has a mechanism of action similar to statins, a daily consumption of between 3 and 10 mg monacolin K has only minimal associated risks, and mild myalgias are seen only in the frailest patients (those who also cannot tolerate minimal dosages of statin). The monacolin K found in RYR is a safe and effective supplement for managing mild to moderate hypercholesterolemia in people with no additional cardiovascular risk factors.
© 2019 Houston Methodist Hospital Houston, Texas.

Entities:  

Keywords:  lipid-lowering supplement; monacolin k; nutraceutical; red yeast rice

Mesh:

Substances:

Year:  2019        PMID: 31687098      PMCID: PMC6822657          DOI: 10.14797/mdcj-15-3-192

Source DB:  PubMed          Journal:  Methodist Debakey Cardiovasc J        ISSN: 1947-6108


  47 in total

1.  Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association.

Authors:  Dariush Mozaffarian; Emelia J Benjamin; Alan S Go; Donna K Arnett; Michael J Blaha; Mary Cushman; Sandeep R Das; Sarah de Ferranti; Jean-Pierre Després; Heather J Fullerton; Virginia J Howard; Mark D Huffman; Carmen R Isasi; Monik C Jiménez; Suzanne E Judd; Brett M Kissela; Judith H Lichtman; Lynda D Lisabeth; Simin Liu; Rachel H Mackey; David J Magid; Darren K McGuire; Emile R Mohler; Claudia S Moy; Paul Muntner; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Graham Nichol; Latha Palaniappan; Dilip K Pandey; Mathew J Reeves; Carlos J Rodriguez; Wayne Rosamond; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Daniel Woo; Robert W Yeh; Melanie B Turner
Journal:  Circulation       Date:  2015-12-16       Impact factor: 29.690

Review 2.  The Role of Nutraceuticals in Statin Intolerant Patients.

Authors:  Maciej Banach; Angelo Maria Patti; Rosaria Vincenza Giglio; Arrigo F G Cicero; Atanas G Atanasov; Gani Bajraktari; Eric Bruckert; Olivier Descamps; Dragan M Djuric; Marat Ezhov; Zlatko Fras; Stephan von Haehling; Niki Katsiki; Michel Langlois; Gustavs Latkovskis; G B John Mancini; Dimitri P Mikhailidis; Olena Mitchenko; Patrick M Moriarty; Paul Muntner; Dragana Nikolic; Demosthenes B Panagiotakos; Gyorgy Paragh; Bernhard Paulweber; Daniel Pella; Christos Pitsavos; Željko Reiner; Giuseppe M C Rosano; Robert S Rosenson; Jacek Rysz; Amirhossein Sahebkar; Maria-Corina Serban; Dragos Vinereanu; Michal Vrablík; Gerald F Watts; Nathan D Wong; Manfredi Rizzo
Journal:  J Am Coll Cardiol       Date:  2018-07-03       Impact factor: 24.094

3.  Efficacy and tolerability of a combined lipid-lowering nutraceutical on cholesterolemia, hs-CRP level and endothelial function in moderately hypercholesterolemic subjects.

Authors:  A F Cicero; A Colletti; M Rosticci; E Grandi; C Borghi
Journal:  J Biol Regul Homeost Agents       Date:  2016 Apr-Jun       Impact factor: 1.711

Review 4.  Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is uncertain - a systematic review and meta-analysis.

Authors:  Maaike C Gerards; Ruben J Terlou; Huixin Yu; C H W Koks; V E A Gerdes
Journal:  Atherosclerosis       Date:  2015-04-12       Impact factor: 5.162

Review 5.  Nutraceuticals as an Important Part of Combination Therapy in Dyslipidaemia.

Authors:  Angelo M Patti; Peter P Toth; Rosaria V Giglio; Maciej Banach; Marcello Noto; Dragana Nikolic; Giuseppe Montalto; Manfredi Rizzo
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

6.  Antihyperlipidaemic effect of a Monascus purpureus brand dietary supplement on a large sample of subjects at low risk for cardiovascular disease: a pilot study.

Authors:  Arrigo F G Cicero; Marco Brancaleoni; Luca Laghi; Franco Donati; Marco Mino
Journal:  Complement Ther Med       Date:  2005-09-09       Impact factor: 2.446

7.  Beneficial impact of Xuezhikang on cardiovascular events and mortality in elderly hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS).

Authors:  Jian-Jun Li; Zong-Liang Lu; Wen-Rong Kou; Zuo Chen; Yang-Feng Wu; Xue-Hai Yu; Yu-Cheng Zhao
Journal:  J Clin Pharmacol       Date:  2009-08       Impact factor: 3.126

8.  Characterization of a non-pigment producing Monascus purpureus mutant strain.

Authors:  Tanya V Rasheva; Trayana S Nedeva; Jean-Noel Hallet; Anna V Kujumdzieva
Journal:  Antonie Van Leeuwenhoek       Date:  2003       Impact factor: 2.271

9.  Effect of red yeast rice combined with antioxidants on lipid pattern, hs-CRP level, and endothelial function in moderately hypercholesterolemic subjects.

Authors:  Arrigo F G Cicero; Martino Morbini; Angelo Parini; Riccardo Urso; Martina Rosticci; Elisa Grandi; Claudio Borghi
Journal:  Ther Clin Risk Manag       Date:  2016-02-23       Impact factor: 2.423

10.  Is statin-modified reduction in lipids the most important preventive therapy for cardiovascular disease? A pro/con debate.

Authors:  F D Richard Hobbs; Maciej Banach; Dimitri P Mikhailidis; Aseem Malhotra; Simon Capewell
Journal:  BMC Med       Date:  2016-01-14       Impact factor: 8.775

View more
  14 in total

Review 1.  Nonalcoholic Fatty Liver Disease: Pathogenesis and Treatment in Traditional Chinese Medicine and Western Medicine.

Authors:  Tingting Shi; Li Wu; Wenjun Ma; Liping Ju; Minghui Bai; Xiaowei Chen; Shourong Liu; Xingxin Yang; Junping Shi
Journal:  Evid Based Complement Alternat Med       Date:  2020-01-04       Impact factor: 2.629

2.  A Randomized, Double-Blinded, Placebo-Controlled, Clinical Study of the Effects of a Nutraceutical Combination (LEVELIP DUO®) on LDL Cholesterol Levels and Lipid Pattern in Subjects with Sub-Optimal Blood Cholesterol Levels (NATCOL Study).

Authors:  Arrigo F G Cicero; Sergio D'Addato; Claudio Borghi
Journal:  Nutrients       Date:  2020-10-14       Impact factor: 5.717

3.  Modulation of the Gut Microbiota and Liver Transcriptome by Red Yeast Rice and Monascus Pigment Fermented by Purple Monascus SHM1105 in Rats Fed with a High-Fat Diet.

Authors:  Hua Yang; Ronghua Pan; Jing Wang; Lizhong Zheng; Zhenjing Li; Qingbin Guo; Changlu Wang
Journal:  Front Pharmacol       Date:  2021-01-21       Impact factor: 5.810

4.  Efficacy and Safety of Armolipid Plus®: An Updated PRISMA Compliant Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.

Authors:  Arrigo F G Cicero; Cormac Kennedy; Tamara Knežević; Marilisa Bove; Coralie M G Georges; Agnė Šatrauskienė; Peter P Toth; Federica Fogacci
Journal:  Nutrients       Date:  2021-02-16       Impact factor: 5.717

Review 5.  Natural Bioactive Compounds Useful in Clinical Management of Metabolic Syndrome.

Authors:  Annalisa Noce; Manuela Di Lauro; Francesca Di Daniele; Anna Pietroboni Zaitseva; Giulia Marrone; Patrizia Borboni; Nicola Di Daniele
Journal:  Nutrients       Date:  2021-02-16       Impact factor: 5.717

6.  Comparing the effectiveness of Chinese patent medicines containing red yeast rice on hyperlipidaemia: A network meta-analysis of randomized controlled trials.

Authors:  Guiqin Xu; Mingxin Lin; Xueli Dai; Jingqing Hu
Journal:  Endocrinol Diabetes Metab       Date:  2021-11-11

Review 7.  A Review of Red Yeast Rice, a Traditional Fermented Food in Japan and East Asia: Its Characteristic Ingredients and Application in the Maintenance and Improvement of Health in Lipid Metabolism and the Circulatory System.

Authors:  Hiroyuki Fukami; Yuki Higa; Tomohiro Hisano; Koichi Asano; Tetsuya Hirata; Sansei Nishibe
Journal:  Molecules       Date:  2021-03-15       Impact factor: 4.411

Review 8.  Red Yeast Rice for Hyperlipidemia: A Meta-Analysis of 15 High-Quality Randomized Controlled Trials.

Authors:  Pengfan Li; Qi Wang; Kanjun Chen; Shihui Zou; Shi Shu; Chanchan Lu; Shiyun Wang; Yunqin Jiang; Chunxiang Fan; Yue Luo
Journal:  Front Pharmacol       Date:  2022-01-17       Impact factor: 5.810

9.  Comparative Effect of Bergamot Polyphenolic Fraction and Red Yeast Rice Extract in Rats Fed a Hyperlipidemic Diet: Role of Antioxidant Properties and PCSK9 Expression.

Authors:  Rocco Mollace; Roberta Macrì; Annamaria Tavernese; Micaela Gliozzi; Vincenzo Musolino; Cristina Carresi; Jessica Maiuolo; Massimo Fini; Maurizio Volterrani; Vincenzo Mollace
Journal:  Nutrients       Date:  2022-01-22       Impact factor: 5.717

Review 10.  Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?

Authors:  Arrigo F G Cicero; Federica Fogacci; Anca Pantea Stoian; Michal Vrablik; Khalid Al Rasadi; Maciej Banach; Peter P Toth; Manfredi Rizzo
Journal:  Curr Atheroscler Rep       Date:  2021-08-04       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.